Eli Lilly to invest $4.5 billion in new manufacturing facilities across Indiana

Eli Lilly announced a $4.5 billion allocation for new manufacturing projects in Indiana. The company said the funds will be used to build and upgrade production sites across the state, expanding its domestic capacity.

The investment reflects a broader trend of pharmaceutical companies increasing U.S. manufacturing footprints, aiming to reduce reliance on overseas supply chains and meet growing demand.

By committing the money to its home region, Lilly underscores its long-standing ties to Indianapolis and signals confidence in the local workforce and infrastructure.